Literature DB >> 32738389

The treatment of intervertebral disc degeneration using Traditional Chinese Medicine.

Liguo Zhu1, Changsui Yu2, Xiaofeng Zhang3, Zhongbao Yu4, Fengyuan Zhan4, Xin Yu5, Shuren Wang6, Feng He1, Yusheng Han5, He Zhao7.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Intervertebral disc degeneration (IDD) is one of the most common causes of chronic low back pain that spending a lot of workforces and financial resources, seriously affecting human physical and mental health. Clinically used drug treatments and surgical treatments cannot fundamentally relieve the disease and have a risk of recurrence. Traditional Chinese Medicine (TCM) has a history of more than a thousand years in the prevention and treatment of IDD. However, so far, there are few reviews on the treatment of IDD by TCM. Therefore, it is crucial and necessary to systematically mine the existing literature on the treatment of IDD with TCM. This paper strives to systematically describe the modern medicine and TCM theoretical research on IDD, progress in the treatment of IDD and focuses on the treatment of IDD by TCM, which would lay some theoretical foundation and provide new directions for future research.
MATERIALS AND METHODS: Information on clinical observations, animal experiments and relevant pharmacology data about the treatment of IDD were gathered from various sources including traditional Chinese books and Chinese Pharmacopoeia, scientific databases (Elsevier, PubMed, Science Direct, Baidu Scholar, CNKI, Spring Link, Web of Science) and from different professional websites.
RESULTS: This review mainly introduces the current research on the theoretical research on IDD, the combination principle of the TCM formula, and the underlying mechanism of the formula and active ingredients.
CONCLUSIONS: At present, domestic and foreign scholars have carried out a lot of research in different ways, such as the molecular mechanism and predisposing factors of IDD, which provides theoretical development and clinical practice significance for future research. TCM, as a multi-component and multi-targeted drug, can produce synergistic effects to exert its efficacy. Therefore, the development of TCM with more specific functions and practical data will not only become a significant trend in the world market but also has an irreplaceable role in the future treatment of IDD.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Year:  2020        PMID: 32738389     DOI: 10.1016/j.jep.2020.113117

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  11 in total

1.  Graded-Three-Dimensional Cell-Encapsulating Hydrogel as a Potential Biologic Scaffold for Disc Tissue Engineering.

Authors:  Zhixiang Li; Yiwen Zhang; Yupeng Zhao; Xubin Gao; Zhonglian Zhu; Yingji Mao; Taibao Qian
Journal:  Tissue Eng Regen Med       Date:  2022-08-13       Impact factor: 4.451

2.  Arctigenin inhibits apoptosis, extracellular matrix degradation, and inflammation in human nucleus pulposus cells by up-regulating miR-483-3p.

Authors:  Zhe Ji; Rui Guo; Zhigang Ma; Hongwei Li
Journal:  J Clin Lab Anal       Date:  2022-06-11       Impact factor: 3.124

3.  Luteolin suppresses TNF-α-induced inflammatory injury and senescence of nucleus pulposus cells via the Sirt6/NF-κB pathway.

Authors:  Tian Xie; Jun Yuan; Ling Mei; Ping Li; Ruijie Pan
Journal:  Exp Ther Med       Date:  2022-05-26       Impact factor: 2.751

4.  Hydroxysafflor Yellow A (HSYA) Protects Endplate Chondrocytes Against IL-1β-Induced Injury Through Promoting Autophagy.

Authors:  Zongyu Zhang; Yongfeng Huo; Zhijing Zhou; Peng Zhang; Jun Hu
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-04       Impact factor: 2.650

5.  Arctiin-reinforced antioxidant microcarrier antagonizes osteoarthritis progression.

Authors:  Yang Liu; Mingzhuang Hou; Zejun Pan; Xin Tian; Zhijian Zhao; Tao Liu; Huilin Yang; Qin Shi; Xi Chen; Yijian Zhang; Fan He; Xuesong Zhu
Journal:  J Nanobiotechnology       Date:  2022-06-27       Impact factor: 9.429

6.  Bushen Huoxue Formula Modulates Autophagic Flux and Inhibits Apoptosis to Protect Nucleus Pulposus Cells by Restoring the AMPK/SIRT1 Pathway.

Authors:  Shang Gao; Nianhu Li; Renchang Chen; Youxiang Su; Yun Song; Songlin Liang
Journal:  Biomed Res Int       Date:  2022-05-27       Impact factor: 3.246

7.  Herbal Formula Modified Bu-Shen-Huo-Xue Decoction Attenuates Intervertebral Disc Degeneration via Regulating Inflammation and Oxidative Stress.

Authors:  Jialiang Lin; Jionghui Gu; Dongwei Fan; Weishi Li
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-02       Impact factor: 2.629

8.  Pharmacological Mechanism of Danggui-Sini Formula for Intervertebral Disc Degeneration: A Network Pharmacology Study.

Authors:  Longjie Wang; Jialiang Lin; Weishi Li
Journal:  Biomed Res Int       Date:  2021-11-11       Impact factor: 3.411

Review 9.  Targeting Oxidative Stress and Inflammation in Intervertebral Disc Degeneration: Therapeutic Perspectives of Phytochemicals.

Authors:  Liang Kang; Huaqing Zhang; Chongyu Jia; Renjie Zhang; Cailiang Shen
Journal:  Front Pharmacol       Date:  2022-07-12       Impact factor: 5.988

10.  Sodium Tanshinone IIA Sulfonate Ameliorates Injury-Induced Oxidative Stress and Intervertebral Disc Degeneration in Rats by Inhibiting p38 MAPK Signaling Pathway.

Authors:  Shouqian Dai; Xiu Shi; Rongqing Qin; Xing Zhang; Feng Xu; Huilin Yang
Journal:  Oxid Med Cell Longev       Date:  2021-05-25       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.